Wolf, Myles

Publications

Sort by

Co-Author Network

selected publications

Short and long-term effects of kidney donation on mineral and bone metabolism. BMC nephrology. 2024 Academic Article GET IT
Author Correction: IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial. 2024 GET IT
IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial. Nature medicine. 2024 Academic Article GET IT
Times cited: 1
Risk factors for hip and vertebral fractures in chronic kidney disease: the CRIC study. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2024 Academic Article GET IT
Times cited: 2
Klotho and Clinical Outcomes in CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2024 Academic Article GET IT
Times cited: 1
Intravenous iron-induced hypophosphatemia and kidney stone disease. 2024 GET IT
Targeting Gut Microbiome With Prebiotic in Patients With CKD: The TarGut-CKD Study. Kidney international reports. 2023 Academic Article GET IT
Times cited: 2
Fibroblast Growth Factor (FGF) 23 and FGF Receptor 4 promote cardiac metabolic remodeling in chronic kidney disease. 2023 GET IT
Calcium and Phosphate Disorders: Core Curriculum 2024. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2023 Review GET IT
Incidence, mechanism, and consequences of IV iron-induced hypophosphatemia. Hematology. American Society of Hematology. Education Program. 2023 Academic Article GET IT
Times cited: 2
Oral Sodium Bicarbonate and Bone Turnover in CKD: A Secondary Analysis of the BASE Pilot Trial. Journal of the American Society of Nephrology : JASN. 2023 Academic Article GET IT
Times cited: 3
Plasma Serotonin and Cardiovascular Outcomes in Chronic Kidney Disease. Journal of the American Heart Association. 2023 Academic Article GET IT
FGF23 and klotho at the intersection of kidney and cardiovascular disease. Nature reviews. Cardiology. 2023 Review GET IT
Times cited: 24
Vitamin D Metabolites and Risk of Cardiovascular Disease in Chronic Kidney Disease: The CRIC Study. Journal of the American Heart Association. 2023 Academic Article GET IT
Times cited: 3
Response to Alkali Administration in Women and Men With and Without CKD. Kidney medicine. 2023 Academic Article GET IT
Renal proximal tubule cells: power and finesse. The Journal of clinical investigation. 2023 Comment GET IT
Times cited: 3
Sildenafil and Kidney Function in Heart Failure with Preserved Ejection Fraction. Kidney360. 2023 Academic Article GET IT
Hepatic and renal improvements with FXR agonist vonafexor in individuals with suspected fibrotic NASH. Journal of hepatology. 2022 Academic Article GET IT
Times cited: 32
Exploring US internal medicine resident career preferences: a Q-methodology study. Advances in health sciences education : theory and practice. 2022 Academic Article GET IT
Times cited: 1
Exercising the FGF23-Cardiac Axis. Kidney360. 2022 Editorial Article GET IT
Times cited: 2
Hypophosphataemia following ferric derisomaltose and ferric carboxymaltose in patients with iron deficiency anaemia due to inflammatory bowel disease (PHOSPHARE-IBD): a randomised clinical trial. Gut. 2022 Academic Article GET IT
Times cited: 22
Supermarket Proximity and Risk of Hypertension, Diabetes, and CKD: A Retrospective Cohort Study. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2022 Academic Article GET IT
Times cited: 7
The American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Secondary and Tertiary Renal Hyperparathyroidism. Annals of surgery. 2022 Academic Article GET IT
Times cited: 40
Risk Factors for and Effects of Persistent and Severe Hypophosphatemia Following Ferric Carboxymaltose. The Journal of clinical endocrinology and metabolism. 2022 Academic Article GET IT
Times cited: 21
A Comparative Study of Serum Phosphate and Related Parameters in Chronic Kidney Disease between the USA and Japan. American journal of nephrology. 2022 Academic Article GET IT
Times cited: 4
Risk Prediction Models for Atherosclerotic Cardiovascular Disease in Patients with Chronic Kidney Disease: The CRIC Study. Journal of the American Society of Nephrology : JASN. 2022 Academic Article GET IT
Times cited: 13
Association of circulating cardiac biomarkers with electrocardiographic abnormalities in chronic kidney disease. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2021 Academic Article GET IT
Times cited: 8
Fibroblast growth factor-23 and subclinical markers of cardiac dysfunction: The coronary artery risk development in young adults (CARDIA) study. American heart journal. 2021 Academic Article GET IT
Times cited: 4
Race, Genetic Ancestry, and Estimating Kidney Function in CKD. The New England journal of medicine. 2021 Academic Article GET IT
Times cited: 148
Hypophosphatemia after intravenous iron therapy: Comprehensive review of clinical findings and recommendations for management. Bone. 2021 Review GET IT
Times cited: 46
Noninvasive Risk Score to Screen for Pulmonary Hypertension With Elevated Pulmonary Vascular Resistance in Diseases of Chronic Volume Overload. The American journal of cardiology. 2021 Academic Article GET IT
Fibroblast Growth Factor 23 and Incident Cardiovascular Disease and Mortality in Middle-Aged Adults. Journal of the American Heart Association. 2021 Academic Article GET IT
Times cited: 10
Lipocalin 2 stimulates bone fibroblast growth factor 23 production in chronic kidney disease. Bone research. 2021 Academic Article GET IT
Times cited: 28
Iron status, fibroblast growth factor 23 and cardiovascular and kidney outcomes in chronic kidney disease. Kidney international. 2021 Academic Article GET IT
Times cited: 21
Intravenous Iron-Induced Hypophosphatemia: An Emerging Syndrome. Advances in therapy. 2021 Review GET IT
Times cited: 19
Time-Updated Changes in Estimated GFR and Proteinuria and Major Adverse Cardiac Events: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2021 Academic Article GET IT
Times cited: 10
Pivoting From PTH to FGF23 to Mend Breaking Hearts on Dialysis. Circulation research. 2021 Editorial Article GET IT
Times cited: 3
Safety and efficacy of iron isomaltoside 1000/ferric derisomaltose versus iron sucrose in patients with chronic kidney disease: the FERWON-NEPHRO randomized, open-label, comparative trial. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2021 Academic Article GET IT
Times cited: 60
Change in Cardiac Biomarkers and Risk of Incident Heart Failure and Atrial Fibrillation in CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2020 Academic Article GET IT
Times cited: 19
Hypophosphataemia after treatment of iron deficiency with intravenous ferric carboxymaltose or iron isomaltoside-a systematic review and meta-analysis. British journal of clinical pharmacology. 2020 Review GET IT
Times cited: 68
Design and Rationale of HiLo: A Pragmatic, Randomized Trial of Phosphate Management for Patients Receiving Maintenance Hemodialysis. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2020 Academic Article GET IT
Times cited: 27
Safety of ferric derisomaltose and iron sucrose in patients with iron deficiency anemia: The FERWON-IDA/NEPHRO trials. American journal of hematology. 2020 Letter GET IT
Times cited: 13
Fibroblast Growth Factor 23 and Exercise Capacity in Heart Failure with Preserved Ejection Fraction. Journal of cardiac failure. 2020 Academic Article GET IT
Times cited: 8
Echocardiography to Screen for Pulmonary Hypertension in CKD. Kidney international reports. 2020 Academic Article GET IT
Times cited: 3
Mineral bone disease in autosomal dominant polycystic kidney disease. Kidney international. 2020 Academic Article GET IT
Times cited: 17
Novel Risk Factors for Progression of Diabetic and Nondiabetic CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2020 Academic Article GET IT
Times cited: 49
Association between patient race and staff resuscitation efforts after cardiac arrest in outpatient dialysis clinics: A study from the CARES surveillance group. Resuscitation. 2020 Academic Article GET IT
Times cited: 8
Mechanism of action of SNF472, a novel calcification inhibitor to treat vascular calcification and calciphylaxis. British journal of pharmacology. 2020 Academic Article GET IT
Times cited: 28
The Nephrology Immersion Classroom for Internal Medicine Residents. Kidney360. 2020 Academic Article GET IT
Times cited: 1
Drug Development in Kidney Disease: Proceedings From a Multistakeholder Conference. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2020 Review GET IT
Times cited: 3
Anemia and Incident End-Stage Kidney Disease. Kidney360. 2020 Academic Article GET IT
Times cited: 10
Effects of ferric carboxymaltose on markers of mineral and bone metabolism: A single-center prospective observational study of women with iron deficiency. Bone. 2020 Academic Article GET IT
Times cited: 9
Nephropathic Cystinosis: A Distinct Form of CKD-Mineral and Bone Disorder that Provides Novel Insights into the Regulation of FGF23. Journal of the American Society of Nephrology : JASN. 2020 Academic Article GET IT
Times cited: 10
Fibroblast Growth Factor 23 and Risk of Hospitalization with Infection in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort (CRIC) Study. Journal of the American Society of Nephrology : JASN. 2020 Academic Article GET IT
Times cited: 15
Inflammatory Markers and Incidence of Hospitalization With Infection in Chronic Kidney Disease. American journal of epidemiology. 2020 Academic Article GET IT
Times cited: 11
Health Outcomes With Vitamin D Supplementation-Reply. JAMA. 2020 Letter GET IT
Kidney Functional Magnetic Resonance Imaging and Change in eGFR in Individuals with CKD. Clinical journal of the American Society of Nephrology : CJASN. 2020 Academic Article GET IT
Times cited: 34
Targeting Vascular Calcification in Chronic Kidney Disease. JACC. Basic to translational science. 2020 Review GET IT
Times cited: 109
Fibroblast Growth Factor-23 and a Vegetarian Diet. Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation. 2020 Academic Article GET IT
Times cited: 2
Racial Differences in the Associations Between Food Insecurity and Fibroblast Growth Factor 23 in the Coronary Artery Risk Development in Young Adults Study. Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation. 2020 Academic Article GET IT
Times cited: 7
Kidney to bone via bedside to bench…and back?. The Journal of clinical investigation. 2020 Comment GET IT
Times cited: 1
Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia: Two Randomized Clinical Trials. JAMA. 2020 Academic Article GET IT
Times cited: 177
Creatinine versus cystatin C for renal function-based mortality prediction in an elderly cohort: The Northern Manhattan Study. PloS one. 2020 Academic Article GET IT
Times cited: 23
Serial Fibroblast Growth Factor 23 Measurements and Risk of Requirement for Kidney Replacement Therapy: The CRIC (Chronic Renal Insufficiency Cohort) Study. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2019 Academic Article GET IT
Times cited: 14
A Randomized Trial Comparing the Safety, Adherence, and Pharmacodynamics Profiles of Two Doses of Sodium Bicarbonate in CKD: the BASE Pilot Trial. Journal of the American Society of Nephrology : JASN. 2019 Academic Article GET IT
Times cited: 41
Vitamin D and Health Outcomes: Then Came the Randomized Clinical Trials. JAMA. 2019 Academic Article GET IT
Times cited: 28
Pulmonary Hypertension Subtypes and Mortality in CKD. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2019 Academic Article GET IT
Times cited: 38
Longitudinal Evolution of Markers of Mineral Metabolism in Patients With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2019 Academic Article GET IT
Times cited: 43
FGFR4 does not contribute to progression of chronic kidney disease. Scientific reports. 2019 Academic Article GET IT
Times cited: 9
FGF23 at the crossroads of phosphate, iron economy and erythropoiesis. Nature reviews. Nephrology. 2019 Review GET IT
Times cited: 168
Does a rise in plasma erythropoietin after high-altitude exposure affect FGF23 in healthy volunteers on a normal or low-phosphorus diet?. Nutrition, metabolism, and cardiovascular diseases : NMCD. 2019 Academic Article GET IT
Times cited: 4
Editorial: awareness and prevention of intravenous iron-induced hypophosphataemia. Alimentary pharmacology & therapeutics. 2019 Editorial Article GET IT
Times cited: 1
Ferric citrate reduces fibroblast growth factor 23 levels and improves renal and cardiac function in a mouse model of chronic kidney disease. Kidney international. 2019 Academic Article GET IT
Times cited: 47
Vitamin D Metabolic Ratio and Risks of Death and CKD Progression. Kidney international reports. 2019 Academic Article GET IT
Times cited: 18
Single Measurements of Carboxy-Terminal Fibroblast Growth Factor 23 and Clinical Risk Prediction of Adverse Outcomes in CKD. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2019 Academic Article GET IT
Times cited: 13
Cardiac Biomarkers and Risk of Atrial Fibrillation in Chronic Kidney Disease: The CRIC Study. Journal of the American Heart Association. 2019 Academic Article GET IT
Times cited: 25
A Pilot Randomized Trial of Ferric Citrate Coordination Complex for the Treatment of Advanced CKD. Journal of the American Society of Nephrology : JASN. 2019 Academic Article GET IT
Times cited: 56
Association of Fitness With Racial Differences in Chronic Kidney Disease. American journal of preventive medicine. 2019 Academic Article GET IT
Times cited: 4
GFR-Specific versus GFR-Agnostic Cutoffs for Parathyroid Hormone and Fibroblast Growth Factor-23 in Advanced Chronic Kidney Disease. American journal of nephrology. 2019 Academic Article GET IT
Times cited: 8
Randomised clinical trial of ferric citrate hydrate on anaemia management in haemodialysis patients with hyperphosphataemia: ASTRIO study. Scientific reports. 2019 Academic Article GET IT
Times cited: 21
Effects of Nicotinamide and Lanthanum Carbonate on Serum Phosphate and Fibroblast Growth Factor-23 in CKD: The COMBINE Trial. Journal of the American Society of Nephrology : JASN. 2019 Academic Article GET IT
Times cited: 88
Effects of etelcalcetide on fibroblast growth factor 23 in patients with secondary hyperparathyroidism receiving hemodialysis. Clinical kidney journal. 2019 Academic Article GET IT
Times cited: 21
DMP1 prevents osteocyte alterations, FGF23 elevation and left ventricular hypertrophy in mice with chronic kidney disease. Bone research. 2019 Academic Article GET IT
Times cited: 63
Serum Calcification Propensity and Coronary Artery Calcification Among Patients With CKD: The CRIC (Chronic Renal Insufficiency Cohort) Study. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2019 Academic Article GET IT
Times cited: 56
Predictors of Net Acid Excretion in the Chronic Renal Insufficiency Cohort (CRIC) Study. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2019 Academic Article GET IT
Times cited: 6
Fibroblast Growth Factor 23 Trajectories in Chronic Hemodialysis Patients: Lessons from the HEMO Study. American journal of nephrology. 2019 Academic Article GET IT
Times cited: 12
The effects of tenapanor on serum fibroblast growth factor 23 in patients receiving hemodialysis with hyperphosphatemia. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2019 Academic Article GET IT
Times cited: 33
Fibroblast Growth Factor-23, Heart Failure Risk, and Renin-Angiotensin-Aldosterone-System Blockade in Hypertension: The MESA Study. American journal of hypertension. 2019 Academic Article GET IT
Times cited: 16
Good Guys, Bad Guys, Guesses, and Near Misses in Nephrology. Clinical journal of the American Society of Nephrology : CJASN. 2018 Editorial Article GET IT
Times cited: 1
Use of Measures of Inflammation and Kidney Function for Prediction of Atherosclerotic Vascular Disease Events and Death in Patients With CKD: Findings From the CRIC Study. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2018 Academic Article GET IT
Times cited: 94
Randomized trial of intravenous iron-induced hypophosphatemia. JCI insight. 2018 Academic Article GET IT
Times cited: 134
Creatinine- versus cystatin C-based renal function assessment in the Northern Manhattan Study. PloS one. 2018 Academic Article GET IT
Times cited: 14
Statins at Dialysis Transition-Supportive but Not Sufficient. JAMA network open. 2018 Comment GET IT
Times cited: 2
Genetic Variants Associated with Circulating Fibroblast Growth Factor 23. Journal of the American Society of Nephrology : JASN. 2018 Review GET IT
Times cited: 30
Sleep disordered breathing and fibroblast growth factor 23 in the Hispanic Community Health Study/Study of Latinos. Bone. 2018 Academic Article GET IT
Times cited: 3
Genetic background influences cardiac phenotype in murine chronic kidney disease. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2018 Academic Article GET IT
Times cited: 24
Metabolic Changes with Base-Loading in CKD. Clinical journal of the American Society of Nephrology : CJASN. 2018 Letter GET IT
Times cited: 6
Incidence and Progression of Chronic Kidney Disease in Black and White Individuals with Type 2 Diabetes. Clinical journal of the American Society of Nephrology : CJASN. 2018 Academic Article GET IT
Times cited: 21
Fibroblast Growth Factor 23 Associates with Death in Critically Ill Patients. Clinical journal of the American Society of Nephrology : CJASN. 2018 Academic Article GET IT
Times cited: 41
Biomarkers of Mineral and Bone Metabolism and 20-Year Risk of Hospitalization With Infection: The Atherosclerosis Risk in Communities Study. The Journal of clinical endocrinology and metabolism. 2017 Academic Article GET IT
Times cited: 10
Longitudinal FGF23 Trajectories and Mortality in Patients with CKD. Journal of the American Society of Nephrology : JASN. 2017 Academic Article GET IT
Times cited: 106
Oral Ferric Citrate Hydrate Associated With Less Oxidative Stress Than Intravenous Saccharated Ferric Oxide. Kidney international reports. 2017 Academic Article GET IT
Times cited: 5
FGF23 and Left Ventricular Hypertrophy in Children with CKD. Clinical journal of the American Society of Nephrology : CJASN. 2017 Academic Article GET IT
Times cited: 76
Prognostic value of bone- and vascular-derived molecular biomarkers in hemodialysis and renal transplant patients: a systematic review and meta-analysis. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2017 Review GET IT
Times cited: 22
Fibroblast Growth Factor 23 and Anemia in the Chronic Renal Insufficiency Cohort Study. Clinical journal of the American Society of Nephrology : CJASN. 2017 Academic Article GET IT
Times cited: 58
Effects of Vitamin D₂ Supplementation on Vitamin D₃ Metabolism in Health and CKD. Clinical journal of the American Society of Nephrology : CJASN. 2017 Academic Article GET IT
Times cited: 36
FGF23 and Nutritional Metabolism. Annual review of nutrition. 2017 Review GET IT
Times cited: 24
Fibroblast Growth Factor 23 and Kidney Disease Progression in Autosomal Dominant Polycystic Kidney Disease. Clinical journal of the American Society of Nephrology : CJASN. 2017 Academic Article GET IT
Times cited: 22
Something old, something new, something borrowed, something black. Current opinion in nephrology and hypertension. 2017 Editorial Article GET IT
Times cited: 2
Acid Load and Phosphorus Homeostasis in CKD. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2017 Academic Article GET IT
Times cited: 31
Coronary Artery Calcification and Risk of Cardiovascular Disease and Death Among Patients With Chronic Kidney Disease. JAMA cardiology. 2017 Academic Article GET IT
The Authors Reply. Kidney international. 2017 Letter GET IT
FGF23/FGFR4-mediated left ventricular hypertrophy is reversible. Scientific reports. 2017 Academic Article GET IT
Times cited: 92
Statistical Methods for Cohort Studies of CKD: Survival Analysis in the Setting of Competing Risks. Clinical journal of the American Society of Nephrology : CJASN. 2017 Academic Article GET IT
Times cited: 55
Second Chances to Improve ESRD Outcomes With a Second-Generation Calcimimetic. JAMA. 2017 Editorial Article GET IT
Times cited: 5
Serum levels of fibroblast growth factor 23 are elevated in patients with active Lupus nephritis. Cytokine. 2017 Academic Article GET IT
Times cited: 11
Fibroblast Growth Factor 23 Levels Associate with AKI and Death in Critical Illness. Journal of the American Society of Nephrology : JASN. 2016 Academic Article GET IT
Times cited: 76
Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease. Kidney international. 2016 Academic Article GET IT
Times cited: 96
Dietary factors and fibroblast growth factor-23 levels in young adults with African ancestry. Journal of bone and mineral metabolism. 2016 Academic Article GET IT
Times cited: 9
Genetic Variants Associated with Circulating Parathyroid Hormone. Journal of the American Society of Nephrology : JASN. 2016 Academic Article GET IT
Times cited: 47
Higher net acid excretion is associated with a lower risk of kidney disease progression in patients with diabetes. Kidney international. 2016 Academic Article GET IT
Times cited: 47
Asymptomatic Ventricular Arrhythmia and Clinical Outcomes in Chronic Kidney Disease: A Pilot Study. Cardiorenal medicine. 2016 Academic Article GET IT
Times cited: 8
Fibroblast Growth Factor 23 and Risk of CKD Progression in Children. Clinical journal of the American Society of Nephrology : CJASN. 2016 Academic Article GET IT
Times cited: 66
Fibroblast Growth Factor 23 and Cause-Specific Mortality in the General Population: The Northern Manhattan Study. The Journal of clinical endocrinology and metabolism. 2016 Academic Article GET IT
Times cited: 69
Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease. Kidney international. 2016 Academic Article GET IT
Times cited: 286
Mineral metabolism: progress in the face of complexity. Current opinion in nephrology and hypertension. 2016 Editorial Article GET IT
Race/Ethnicity and Cardiovascular Outcomes in Adults With CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic CRIC Studies. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2016 Academic Article GET IT
Times cited: 28
Atrial Fibrillation and Risk of ESRD in Adults with CKD. Clinical journal of the American Society of Nephrology : CJASN. 2016 Academic Article GET IT
Times cited: 73
Fibroblast Growth Factor-23 (FGF-23) Levels Differ Across Populations by Degree of Industrialization. The Journal of clinical endocrinology and metabolism. 2016 Academic Article GET IT
Times cited: 19
Fibroblast growth factor 23 levels are elevated and associated with severe acute kidney injury and death following cardiac surgery. Kidney international. 2016 Academic Article GET IT
Times cited: 70
Cord Blood Ferritin and Fibroblast Growth Factor-23 Levels in Neonates. The Journal of clinical endocrinology and metabolism. 2016 Academic Article GET IT
Times cited: 16
Genetic African Ancestry and Markers of Mineral Metabolism in CKD. Clinical journal of the American Society of Nephrology : CJASN. 2016 Academic Article GET IT
Times cited: 14
Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production. Kidney international. 2016 Academic Article GET IT
Times cited: 380
A Prospective Cohort Study of Mineral Metabolism After Kidney Transplantation. Transplantation. 2016 Academic Article GET IT
Times cited: 119
Examination of Potential Modifiers of the Association of APOL1 Alleles with CKD Progression. Clinical journal of the American Society of Nephrology : CJASN. 2015 Academic Article GET IT
Times cited: 30
Mineral (Mal)Adaptation to Kidney Disease--Young Investigator Award Address: American Society of Nephrology Kidney Week 2014. Clinical journal of the American Society of Nephrology : CJASN. 2015 Conference Paper GET IT
Times cited: 29
When there will never be a randomized controlled trial. Kidney international. 2015 Comment GET IT
Times cited: 10
Bones and stones, edition 2015. Current opinion in nephrology and hypertension. 2015 Editorial Article GET IT
Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD. Journal of the American Society of Nephrology : JASN. 2015 Review GET IT
Times cited: 118
Phosphate, fibroblast growth factor 23 and retinopathy in chronic kidney disease: the Chronic Renal Insufficiency Cohort Study. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2015 Academic Article GET IT
Times cited: 12
Serum Phosphorus and Progression of CKD and Mortality: A Meta-analysis of Cohort Studies. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2015 Review GET IT
Times cited: 115
A 12-week, double-blind, placebo-controlled trial of ferric citrate for the treatment of iron deficiency anemia and reduction of serum phosphate in patients with CKD Stages 3-5. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2014 Academic Article GET IT
Times cited: 120
Impact of westernization on fibroblast growth factor 23 levels among individuals of African ancestry. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2014 Academic Article GET IT
Times cited: 20
Vitamin D therapy in individuals with prehypertension or hypertension: the DAYLIGHT trial. Circulation. 2014 Academic Article GET IT
Times cited: 100
Fibroblast growth factor 23 and incident CKD in type 2 diabetes. Clinical journal of the American Society of Nephrology : CJASN. 2014 Academic Article GET IT
Times cited: 24
Klotho and phosphate are modulators of pathologic uremic cardiac remodeling. Journal of the American Society of Nephrology : JASN. 2014 Academic Article GET IT
Times cited: 227
High-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide (NT-proBNP) and risk of incident heart failure in patients with CKD: the Chronic Renal Insufficiency Cohort (CRIC) Study. Journal of the American Society of Nephrology : JASN. 2014 Academic Article GET IT
Times cited: 105
The biomarker niche for fibroblast growth factor 23 testing in CKD. Journal of the American Society of Nephrology : JASN. 2014 Editorial Article GET IT
Times cited: 6
Coupling fibroblast growth factor 23 production and cleavage: iron deficiency, rickets, and kidney disease. Current opinion in nephrology and hypertension. 2014 Review GET IT
Times cited: 158
The pursuit of truth and beauty. Current opinion in nephrology and hypertension. 2014 Editorial Article GET IT
Times cited: 1
Treatment of established left ventricular hypertrophy with fibroblast growth factor receptor blockade in an animal model of CKD. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2014 Academic Article GET IT
Times cited: 78
In search of the fountain of youth. Journal of the American Society of Nephrology : JASN. 2014 Editorial Article GET IT
Times cited: 3
Nephrogenic systemic fibrosis is associated with hypophosphataemia: a case-control study. Rheumatology (Oxford, England). 2014 Academic Article GET IT
Times cited: 7
Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease. Nature reviews. Nephrology. 2014 Review GET IT
Times cited: 160
Increasing use of vitamin D supplementation in the chronic renal insufficiency cohort study. Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation. 2014 Academic Article GET IT
Times cited: 10
Disordered FGF23 and mineral metabolism in children with CKD. Clinical journal of the American Society of Nephrology : CJASN. 2013 Academic Article GET IT
Times cited: 127
Fibroblast growth factor-23 and cardiovascular events in CKD. Journal of the American Society of Nephrology : JASN. 2013 Academic Article GET IT
Times cited: 369
Predictors of high sensitivity cardiac troponin T in chronic kidney disease patients: a cross-sectional study in the chronic renal insufficiency cohort (CRIC). BMC nephrology. 2013 Academic Article GET IT
Times cited: 125
Innovations in bones and stones. Current opinion in nephrology and hypertension. 2013 Editorial Article GET IT
Phosphate homeostasis in CKD: report of a scientific symposium sponsored by the National Kidney Foundation. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2013 Review GET IT
Times cited: 69
Plasma FGF23 levels increase rapidly after acute kidney injury. Kidney international. 2013 Academic Article GET IT
Times cited: 150
A balanced view of calcium and phosphate homeostasis in chronic kidney disease. Kidney international. 2013 Comment GET IT
Times cited: 26
Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2013 Academic Article GET IT
Times cited: 198
Effects of dietary phosphate restriction and phosphate binders on FGF23 levels in CKD. Clinical journal of the American Society of Nephrology : CJASN. 2013 Academic Article GET IT
Times cited: 126
Contemporary mineral metabolism for clinicians and scientists: introduction. Seminars in nephrology. 2013 Editorial Article GET IT
Fibroblast growth factor 23 is not associated with and does not induce arterial calcification. Kidney international. 2013 Academic Article GET IT
Times cited: 278
Mineral metabolites and CKD progression in African Americans. Journal of the American Society of Nephrology : JASN. 2012 Academic Article GET IT
Times cited: 87
αKlotho: FGF23 coreceptor and FGF23-regulating hormone. The Journal of clinical investigation. 2012 Comment GET IT
Times cited: 16
Partial answers from partial Klotho deficiency. Journal of the American Society of Nephrology : JASN. 2012 Editorial Article GET IT
Times cited: 2
A physiologic-based approach to the evaluation of a patient with hyperphosphatemia. 2012 GET IT
Times cited: 8
Expression of fgf23 and αklotho in developing embryonic tissues and adult kidney of the zebrafish, Danio rerio. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2012 Academic Article GET IT
Times cited: 28
Fibroblast growth factor 23, high-sensitivity cardiac troponin, and left ventricular hypertrophy in CKD. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2012 Academic Article GET IT
Times cited: 34
Effects of phosphate binders in moderate CKD. Journal of the American Society of Nephrology : JASN. 2012 Academic Article GET IT
Times cited: 456
Mineral metabolism: confusion to clarity. Current opinion in nephrology and hypertension. 2012 Editorial Article GET IT
FGF-23 levels in patients with AKI and risk of adverse outcomes. Clinical journal of the American Society of Nephrology : CJASN. 2012 Academic Article GET IT
Times cited: 79
Update on fibroblast growth factor 23 in chronic kidney disease. Kidney international. 2012 Review GET IT
Times cited: 329
Fibroblast growth factor 23 and Inflammation in CKD. Clinical journal of the American Society of Nephrology : CJASN. 2012 Academic Article GET IT
Times cited: 225
Plant protein intake is associated with fibroblast growth factor 23 and serum bicarbonate levels in patients with chronic kidney disease: the Chronic Renal Insufficiency Cohort study. Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation. 2012 Academic Article GET IT
Times cited: 91
Associations of dietary phosphorus intake, urinary phosphate excretion, and fibroblast growth factor 23 with vascular stiffness in chronic kidney disease. Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation. 2012 Academic Article GET IT
Times cited: 26
Paricalcitol versus cinacalcet plus low-dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: results of the IMPACT SHPT study. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2012 Academic Article GET IT
Times cited: 99
Daily variability in mineral metabolites in CKD and effects of dietary calcium and calcitriol. Clinical journal of the American Society of Nephrology : CJASN. 2012 Academic Article GET IT
Times cited: 49
Associations of socioeconomic status and processed food intake with serum phosphorus concentration in community-living adults: the Multi-Ethnic Study of Atherosclerosis (MESA). Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation. 2012 Academic Article GET IT
Times cited: 20
(1-34) Parathyroid hormone infusion acutely lowers fibroblast growth factor 23 concentrations in adult volunteers. Clinical journal of the American Society of Nephrology : CJASN. 2012 Academic Article GET IT
Times cited: 31
Association of serum calcitonin with coronary artery disease in individuals with and without chronic kidney disease. International urology and nephrology. 2011 Academic Article GET IT
Times cited: 8
Fibroblast growth factor 23, cardiovascular disease risk factors, and phosphorus intake in the health professionals follow-up study. Clinical journal of the American Society of Nephrology : CJASN. 2011 Academic Article GET IT
Times cited: 140
Correlates of osteoprotegerin and association with aortic pulse wave velocity in patients with chronic kidney disease. Clinical journal of the American Society of Nephrology : CJASN. 2011 Academic Article GET IT
Times cited: 49
Fibroblast growth factor 23 in patients undergoing peritoneal dialysis. Clinical journal of the American Society of Nephrology : CJASN. 2011 Academic Article GET IT
Times cited: 76
Phosphate REINs in the renoprotective benefit of ACE inhibition. Journal of the American Society of Nephrology : JASN. 2011 Editorial Article GET IT
Times cited: 1
The beehive and the merry-go-round in mineral metabolism. Current opinion in nephrology and hypertension. 2011 Editorial Article GET IT
Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality. Journal of the American Society of Nephrology : JASN. 2011 Academic Article GET IT
Times cited: 245
Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney international. 2011 Academic Article GET IT
Times cited: 1021
Diuretics, calciuria and secondary hyperparathyroidism in the Chronic Renal Insufficiency Cohort. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2011 Academic Article GET IT
Times cited: 42
Should activated vitamin D be used in patients with end-stage renal disease and low levels of parathyroid hormone?. Seminars in dialysis. 2011 Academic Article GET IT
Times cited: 3
FGF23 or PTH: which comes first in CKD ?. Kidney international. 2010 Comment GET IT
Times cited: 62
FGF23: fashion or physiology?. Clinical journal of the American Society of Nephrology : CJASN. 2010 Editorial Article GET IT
Times cited: 4
Low socioeconomic status associates with higher serum phosphate irrespective of race. Journal of the American Society of Nephrology : JASN. 2010 Academic Article GET IT
Times cited: 93
Vitamin D deficiency, inflammation, and albuminuria in chronic kidney disease: complex interactions. Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation. 2010 Academic Article GET IT
Times cited: 72
Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2010 Academic Article GET IT
Times cited: 153
Recent advances in the rapidly evolving field of fibroblast growth factor 23 in chronic kidney disease. Current opinion in nephrology and hypertension. 2010 Review GET IT
Times cited: 30
Dietary phosphorus restriction in advanced chronic kidney disease: merits, challenges, and emerging strategies. Seminars in dialysis. 2010 Review GET IT
Times cited: 39
Racial differences in postprandial mineral ion handling in health and in chronic kidney disease. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2010 Academic Article GET IT
Times cited: 36
Forging forward with 10 burning questions on FGF23 in kidney disease. Journal of the American Society of Nephrology : JASN. 2010 Review GET IT
Times cited: 256
Impact of poverty on serum phosphate concentrations in the Third National Health and Nutrition Examination Survey. Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation. 2010 Academic Article GET IT
Times cited: 36
Randomized evaluation of efficacy and safety of ferric carboxymaltose in patients with iron deficiency anaemia and impaired renal function (REPAIR-IDA): rationale and study design. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2010 Academic Article GET IT
Times cited: 18
Diagnosis and management of mineral metabolism in CKD. Journal of general internal medicine. 2010 Academic Article GET IT
Times cited: 17
Vitamin D deficiency and anemia in early chronic kidney disease. Kidney international. 2010 Academic Article GET IT
Times cited: 119
Elevated FGF-23 in a patient with rhabdomyolysis-induced acute kidney injury. 2009 GET IT
Times cited: 29
Second chances in mineral metabolism. Clinical journal of the American Society of Nephrology : CJASN. 2009 Editorial Article GET IT
Times cited: 2
Fibroblast growth factor 23 and the future of phosphorus management. Current opinion in nephrology and hypertension. 2009 Review GET IT
Times cited: 44
Klotho variants and chronic hemodialysis mortality. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2009 Academic Article GET IT
Times cited: 56
Integrating research training into residency: tools of human investigation. Academic medicine : journal of the Association of American Medical Colleges. 2009 Academic Article GET IT
Times cited: 14
Chronic kidney disease, hypovitaminosis D, and mortality in the United States. Kidney international. 2009 Academic Article GET IT
Times cited: 194
A blueprint for randomized trials targeting phosphorus metabolism in chronic kidney disease. Kidney international. 2009 Review GET IT
Times cited: 96
Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. Circulation. 2009 Academic Article GET IT
Times cited: 723
Plasma gelsolin and circulating actin correlate with hemodialysis mortality. Journal of the American Society of Nephrology : JASN. 2009 Academic Article GET IT
Times cited: 102
Phosphorus binders and survival on hemodialysis. Journal of the American Society of Nephrology : JASN. 2008 Academic Article GET IT
Times cited: 329
Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. The New England journal of medicine. 2008 Academic Article GET IT
Times cited: 1502
Active vitamin D and survival. Journal of the American Society of Nephrology : JASN. 2008 Editorial Article GET IT
Times cited: 9
N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations in hemodialysis patients: prognostic value of baseline and follow-up measurements. Clinical chemistry. 2008 Academic Article GET IT
Times cited: 36
Calciphylaxis from nonuremic causes: a systematic review. Clinical journal of the American Society of Nephrology : CJASN. 2008 Review GET IT
Times cited: 331
Impact of activated vitamin D and race on survival among hemodialysis patients. Journal of the American Society of Nephrology : JASN. 2008 Academic Article GET IT
Times cited: 160
Prevalence and severity of disordered mineral metabolism in Blacks with chronic kidney disease. Kidney international. 2008 Academic Article GET IT
Times cited: 64
Renal metastases. 2008 GET IT
Times cited: 2
Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD. Journal of the American Society of Nephrology : JASN. 2008 Academic Article GET IT
Times cited: 142
Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008 Academic Article GET IT
Times cited: 2040
Vitamin D levels and early mortality among incident hemodialysis patients. Kidney international. 2007 Academic Article GET IT
Times cited: 724
First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction. American journal of obstetrics and gynecology. 2007 Academic Article GET IT
Times cited: 182
Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Archives of internal medicine. 2007 Academic Article GET IT
Times cited: 743
Predicting gestational diabetes: choosing the optimal early serum marker. American journal of obstetrics and gynecology. 2007 Academic Article GET IT
Times cited: 93
Agonistic angiotensin II type 1 receptor autoantibodies in postpartum women with a history of preeclampsia. Hypertension (Dallas, Tex. : 1979). 2007 Academic Article GET IT
Times cited: 117
Vitamin D in patients with renal failure: a summary of observational mortality studies and steps moving forward. The Journal of steroid biochemistry and molecular biology. 2007 Review GET IT
Times cited: 39
Vitamin D in patients with kidney disease: cautiously optimistic. Advances in chronic kidney disease. 2007 Review GET IT
Times cited: 18
Post-transplant hypophosphatemia: Tertiary 'Hyper-Phosphatoninism'?. Kidney international. 2006 Academic Article GET IT
Times cited: 176
Clinical problem-solving. Needle in a haystack. 2006 GET IT
Times cited: 10
Postpartum diabetes screening in women with a history of gestational diabetes. Obstetrics and gynecology. 2005 Academic Article GET IT
Times cited: 121
Case records of the Massachusetts General Hospital. Case 28-2005. A 42-year-old man with weight loss, weakness, and a rash. The New England journal of medicine. 2005 Conference Paper GET IT
Times cited: 5
Circulating levels of the antiangiogenic marker sFLT-1 are increased in first versus second pregnancies. American journal of obstetrics and gynecology. 2005 Academic Article GET IT
Times cited: 107
Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. Journal of the American Society of Nephrology : JASN. 2005 Academic Article GET IT
Times cited: 784
Early pregnancy insulin resistance and subsequent gestational diabetes mellitus. Diabetes care. 2005 Academic Article GET IT
Times cited: 38
Activated injectable vitamin D and hemodialysis survival: a historical cohort study. Journal of the American Society of Nephrology : JASN. 2005 Academic Article GET IT
Times cited: 775
Beyond minerals and parathyroid hormone: role of active vitamin D in end-stage renal disease. Seminars in dialysis. 2005 Review GET IT
Times cited: 23
Preeclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance. The Journal of clinical endocrinology and metabolism. 2004 Academic Article GET IT
Times cited: 189
Differential risk of hypertensive disorders of pregnancy among Hispanic women. Journal of the American Society of Nephrology : JASN. 2004 Academic Article GET IT
Times cited: 60
Insulin resistance and alterations in angiogenesis: additive insults that may lead to preeclampsia. Hypertension (Dallas, Tex. : 1979). 2004 Academic Article GET IT
Times cited: 94
First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. The Journal of clinical endocrinology and metabolism. 2004 Academic Article GET IT
Times cited: 404
Inflammation and glucose intolerance: a prospective study of gestational diabetes mellitus. Diabetes care. 2004 Academic Article GET IT
Times cited: 129
Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. The New England journal of medicine. 2003 Academic Article GET IT
Times cited: 925
First-trimester sex hormone binding globulin and subsequent gestational diabetes mellitus. American journal of obstetrics and gynecology. 2003 Academic Article GET IT
Times cited: 97
First-trimester C-reactive protein and subsequent gestational diabetes. Diabetes care. 2003 Academic Article GET IT
Times cited: 197
Insulin resistance but not inflammation is associated with gestational hypertension. Hypertension (Dallas, Tex. : 1979). 2002 Academic Article GET IT
Times cited: 51
Clinical research career development: the individual perspective. Academic medicine : journal of the Association of American Medical Colleges. 2002 Academic Article GET IT
Times cited: 26
First trimester insulin resistance and subsequent preeclampsia: a prospective study. The Journal of clinical endocrinology and metabolism. 2002 Academic Article GET IT
Times cited: 198
Patients with Fabry disease on dialysis in the United States. Kidney international. 2002 Academic Article GET IT
Times cited: 189

more ...

less ...

Background

education and training

M.D., State University of New York Health Science Center at Brooklyn 96
M.M.Sc., Harvard Medical School 2002
B.A., The Johns Hopkins University 1992

Contact

full name

Myles Wolf

primary email

myleswo@med.cornell.edu

VIVO Weill Cornell Medical College

Myles Wolf Sanford I. Weill Chair of Medicine

Publications

selected publications

Background

education and training

Contact

full name

primary email